| Optimization of Acetazolamide-Based Scaffold as Potent Inhibitors of Vancomycin-Resistant Enterococcus J Kaur, X Cao, NS Abutaleb, A Elkashif, AL Graboski, AD Krabill, ... Journal of medicinal chemistry 63 (17), 9540-9562, 2020 | 67 | 2020 |
| Structure–Activity Relationship Studies of Acetazolamide-Based Carbonic Anhydrase Inhibitors with Activity against Neisseria gonorrhoeae CS Hewitt, NS Abutaleb, AEM Elhassanny, A Nocentini, X Cao, DP Amos, ... ACS infectious diseases 7 (7), 1969-1984, 2021 | 56 | 2021 |
| Ubiquitin C‐Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine‐Based Inhibitor AD Krabill, H Chen, S Hussain, C Feng, A Abdullah, C Das, UK Aryal, ... ChemBioChem 21 (5), 712-722, 2020 | 41* | 2020 |
| Functional interrogation and therapeutic targeting of protein tyrosine phosphatases AD Krabill, ZY Zhang Biochemical Society Transactions 49 (4), 1723-1734, 2021 | 17 | 2021 |
| Development of ubiquitin variants with selectivity for ubiquitin C-terminal hydrolase deubiquitinases CS Hewitt, AD Krabill, C Das, DP Flaherty Biochemistry 59 (37), 3447-3462, 2020 | 15 | 2020 |
| Optimization and Anti-Cancer Properties of Fluoromethylketones as covalent inhibitors for Ubiquitin C-terminal Hydrolase L1 AD Krabill, H Chen, S Hussain, CS Hewitt, RD Imhoff, CS Muli, C Das, ... Molecules 26 (5), 1227, 2021 | 7 | 2021 |
| Natural product-inspired molecules for covalent inhibition of SHP2 tyrosine phosphatase W Liang, AD Krabill, KS Gallagher, C Muli, Z Qu, D Trader, ZY Zhang, ... Tetrahedron, 133918, 2024 | 1 | 2024 |
| Discovery of the first-in-class SHP1 covalent inhibitor for cancer immunotherapy Z Qu, FN Meke, Z Zhang, Y Bai, AD Krabill, CS Muli, BA Jassim, J Dong, ... Cancer Research 84 (6_Supplement), 1973-1973, 2024 | | 2024 |
| Covalent Fragment Screening and Optimization Identifies the Chloroacetohydrazide Scaffold as Inhibitors for Ubiquitin C-terminal Hydrolase L1 RD Imhoff, R Patel, MH Safdar, HBL Jones, A Pinto-Fernandez, I Vendrell, ... Journal of Medicinal Chemistry 67 (6), 4496-4524, 2024 | | 2024 |
| Altered Protein Dynamics and a More Reactive Catalytic Cysteine in a Neurodegeneration-associated UCHL1 Mutant S Kenny, CH Lai, TS Chiang, K Brown, CS Hewitt, AD Krabill, HT Chang, ... Journal of Molecular Biology 436 (4), 168438, 2024 | | 2024 |
| High-Throughput Discovery and Characterization of Covalent Inhibitors for Protein Tyrosine Phosphatases Z Qu, AD Krabill, ZY Zhang Protein Tyrosine Phosphatases: Methods and Protocols, 301-316, 2023 | | 2023 |
| Development and Characterization of Novel Probes to Elucidate the Role of Ubiquitin C-Terminal Hydrolase L1 in Cancer Biology AD Krabill Purdue University, 2020 | | 2020 |
Daniel P. FlahertyPurdue UniversityVerified email at purdue.edu
